dequate intravenous access is of paramount importance for patients in both acute and community care. Advances in catheter materials and techniques have resulted in a range of vascular access devices being available for use in clinical settings. This article will present an overview of vascular access devices and provide the most relevant information regarding the indications for the use of each device. For the purpose of this article the devices will be divided into short-term, intermediate-term or long-term devices. Abstract A Figure 1 . Peripheral cannula s8
Introduction
Catheters have been inserted into the venous system for almost 100 years ( Kalso, 1985 ) . Initially catheters were used for temporary or short-term access to administer medications such as antibiotics via a peripherally accessed vein. Longer-term venous access became clinically possible with the introduction of silastic, tunnelled catheters ( Hickman et al, 1979 ) . Since then central venous access (CVA) procedures have continued to grow and evolve, as have the indications for placement of these devices. A wide range of professionals are now involved, not only in the care of these devices, but in the insertion and removal of them. Because of the range of vascular access devices (VADs) it is necessary for healthcare professionals to have knowledge of each device, particularly in relation to the indications and contraindications for their use in clinical situations.
Short-term VADs
Peripheral cannula Short-term peripheral cannulae ( Figure 1 ) are the most commonly used VAD in clinical practice. According to Wilson (2001) more than 60% of patients requiring IV therapy receive this via a cannula. Cannulae are usually less than or equal to 3.5 cms in length ( INS, 2006 ) . They are inserted into any superfi cial veins of the arms of adult patients or any superfi cial vein in children and neonates. Peripheral cannulation is a procedure that many nurses are now performing regularly and routinely as part of their role. Risks associated with the use of these devices can be short or medium term, including allergy, plastic or air embolus ( Lavery and Smith, 2007 ) , or long term including nerve injury, nerve compression or injury, necrosis resulting from extravasation, cording/ hardening of the vein, septicaemia (catheter-related bloodstream infection) and thrombosis/thrombophlebitis ( Lavery and Smith, 2007 ) . Therefore consider peripheral cannulae for non-irritant short term treatments:
Short-term IV medication administration Short-term administration of antibiotics Treatment that is required for no more than one week.
Central catheter
Short-term central catheters ( Figure 2 ) are non-tunnelled, 20 to 30 cm polyurethane catheters inserted into a central vein such as the subclavian, internal jugular, innominate, axilliary or femoral ( Gallieni et al, 2008 ) . They may have a single lumen or multiple lumens and are designed for continuous, short-term infusions of one to three weeks. The main advantages of central venous catheters are that they can be inserted relatively easily and quickly and used immediately once tip position has been ascertained. As they can be used for several therapies at the same time and can be used for critically ill patients this makes them highly advantageous. Central lines can be placed in a variety of settings and their use is relatively common. Insertion requires training and there are multiple guidelines relating to their use ( Dougherty, 2006 ) . Complications associated with insertion include pneumothorax/haemothorax, arterial injury and haemorrhage, infection, air embolism and thrombosis ( McGee and Gould, 2003 ) . The use of central venous lines in emergency situations for the treatment of R SUPPLEMENT 1
Peer reviewed paper critically unwell patients further exposes patients to these complications ( Dougherty, 2006 ) . Central venous lines should only be used as a temporary measure due to the high rates of infection associated with these devices ( O'Grady et al, 2002 ) . Consider a short term central catheter for: Short-term access of one to three weeks Measurement of central venous pressure Administration of fl uids and/or toxic drugs in patients who have limited peripheral access Short-term haemodialysis ( Hocking, 2000 ) .
Intermediate-term VADs Midline catheters
Midline catheters, sometimes simply called midlines, ( Figure 3 ) are non-tunnelled peripherally inserted VADs, which are inserted through a peripheral vein in the arm (antecubital, basilic, brachial or cephalic vein). They are usually 7.5-20 cms in length ( INS, 2006 ) . By defi nition their tip is not placed centrally in the superior vena cava but in the basilic or cephalic vein ( Ives, 2009 ). Ultrasound should be utilised to ensure safe placement ( Moureau, 2006 ) . Real-time ultrasound studies have reported a greater percentage of successful cannulations, fewer venepuncture attempts and a decreased time required for cannulation ( Rothschild, 2001 ) . They can be used for a longer period of time than conventional peripheral lines but a shorter duration than a peripherally inserted central catheter (PICC), lasting for approximately two to six weeks ( Royal College of Nursing (RCN), 2005 ).
Since the catheter tip is of a much shorter length, a follow-up chest x-ray is not required to confi rm catheter placement. Midlines do not enter the central system and therefore have the same limitations as peripheral cannulae. They should not be used for caustic infusions such as total parenteral nutrition (TPN) or long-term chemotherapy ( Griffi ths, 2007 ) . Consider a midline for: Antibiotic treatment IV fl uids Administration of blood products Patients with diffi cult IV access.
Peripherally inserted central catheter (PICC)
PICCs ( Figure 4 ) fi rst gained popularity in the 1970s in the United States ( Hoshal, 1975 ) and their use has continued to grow steadily since then ( Brown, 1989 ) . One of the main reasons they have grown in popularity is because of their reduction in potential complications and cost compared to short-term central venous catheters (Thiagarajan et al, 1997) . PICCs are usually manufactured from silicone or polyurethane, and measure approximately 50-60 cms in length. PICC placement is obtained through the veins in the antecubital fossa or upper arm, usually the basilic or cephalic vein, with the tip ideally According to Mazzola et al (1999) the basilic vein offers optimal access. This is due to the fact that it has the greatest blood fl ow, largest diameter and offers the straightest route to the superior vena cava. PICCs are a reliable alternative to short-term central venous catheters, with a lower risk of complications ( Ravi et al, 1997 ) . PICCs are being increasingly used as a means of delivering many types of treatments, in particular chemotherapy ( Bunting et al, 2000 ) . Although incidence of bacteraemia from PICCs is relatively low ( Maki and Ringer, 1991 ; O'Grady et al, 2002 ) , if it does occur it may be life-threatening, especially in immunocompromised patients. The longer the patient has a PICC in situ, the greater the opportunity for micro-organisms to multiply ( Curran et al, 2000 ) . Another common catheter-related infection is phlebitis, which is largely a physicochemical or mechanical phenomenon rather than being infectious ( Curran et al, 2000 ) . When phlebitis occurs there may be an increased risk of developing a local catheter-related infection. The RCN (2005) recommends using a phlebitis scale for assessing and acting upon phlebitis.
Consider a PICC for: Treatment that is required for six weeks to one year Delivery of antibiotic therapy IV fl uid administration Total parenteral nutrition Conditions requiring regular blood sampling Administration of irritants/vesicants including chemotherapy ( Dougherty, 2006 ) .
Long-term VADs Tunnelled central venous catheters (TCVCS) Hickman and Broviac and apheresis catheters
Tunnelled central venous catheters ( Figure 5 ) are inserted directly or indirectly into one of the central veins, either the superior vena cava or the right atrium. These veins both return blood into the right atrium and have the largest blood fl ow of any veins in the body ( Sansivero, 1998 ) . Indications for the use of central venous catheters include drug and fl uid administration, nutrition, antibiotic therapy, chemotherapy, bone marrow transplantation and renal dialysis. A large number of patients from a vast variety of specialties will therefore at some point require tunnelled central venous catheterisation. According to Hamilton and Bodenham (2009) approximately 250,000 catheters are inserted annually in the United Kingdom; continuous access to the central venous circulation is becoming increasingly important in medical and surgical management. TCVCs are soft, fl exible tubes made from various materials including silicone and polyurethane. They are inserted via the jugular, subclavian or femoral vein using the guide wire Seldinger technique. The tip of the catheter rests in the lower third of the superior vena cava or the upper right atrium. The catheters are tunnelled subcutaneously and many are equipped with a fi brous (Dacron) cuff, which sits in the skin tunnel. The cuff induces an infl ammatory reaction within the subcutaneous tunnel which leads to fi brosis and consequent catheter fi xation, usually three to four weeks following insertion. This action makes the catheter more stable ( Pratt et al, 2007 ) . The cuff will also act as a mechanical barrier to prevent infection traversing the line. 
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TCVCs may be open-ended or valved and are available in single, dual or triple lumen. They are available in various diameters or gauges, the most commonly used being 6.6 French to 14 French. TCVCs are more comfortable and discreet than the non-tunnelled catheters, and can remain in situ for up to two years. The placement of a TCVC requires a minimally invasive surgical procedure that carries risks of complication which can be serious or potentially fatal ( Hamilton, 2006 ; McGee and Gould, 2003 ; Polderman and Girbes, 2002 ) . These complications include pneumothorax, haemothorax, haemorrhage, carotid puncture, air embolism and infection ( Macklin and Chernecky, 2004 ) . Consider a TCVC for: Treatment that is required for up to two years Patients with poor venous access -this may have a variety of causes, including drug abuse and obesity Administration of medications with a pH less than fi ve or greater than nine ( INS, 2006 ) Infusates with an osmolarity greater than 500 milliosmoles per litre ( INS, 2006 ) Prolonged intravenous therapy, such as continuous vesicant chemotherapy ( RCN, 2005 ) Plasmaphereis Conditions requiring multiple punctures, such as daily blood withdrawals in patients with coagulopathy Total parenteral nutrition.
Haemodialysis catheters
These catheters are large bore and relatively stiff catheters. They comprise multiple side holes and an end hole to allow satisfactory fl ow rates during haemodialysis. They are available either as two separate catheters that are inserted into the same vein ( Figure 6 ) or as a split catheter (Figure 7 ) . Tunnelled cuffed venous dialysis catheters are the chosen method for temporary access lasting longer than three weeks. They may also be used in patients who have exhausted all other means of access, or in those patients waiting for a fi stula to mature. The two tips should be staggered and ideally be placed at the superior vena cava/right atrium junction and the right atrium ( Ray, 2001 ) . Dialysis catheters are used because: They can be use immediately They can be inserted into multiple sites Venepuncture is not required for dialysis. Long-term access is required to allow maturity of arteriovenous fi stulae They can easily be placed, replaced and removed. ( Duncan et al, 2004 ) Totally implantable ports A totally implantable port (TIP; sometimes referred to as a Porta-Cath, although this is actually a trade name; Figure 8 ) is a venous Peer reviewed paper access device comprising a portal body and attached catheter ( Dougherty, 2006 ) . These devices were fi rst introduced in the early 1980s and used as a form of venous access in oncology patients ( Dougherty, 2006 ) . The main advantage of ports over other venous access devices is that they are implanted and therefore not external to the body ( Dougherty, 2006 ) . Consequently, there is less of an impact on a patient's body image as the port is not seen externally. There is less risk of infection as the port is not exposed to life's daily bacteria. The port, made of stainless steel, titanium or plastic is a hollow reservoir with a latex septum and a side outlet which connects to a silicone or polyurethane catheter. It is this catheter that feeds directly into one of the central veins. To administer treatment the skin overlying the reservoir is punctured with a Huber needle (sometimes referred to as a Gripper needle; Gripper is also a trade name) and it is through this needle that treatment is delivered ( Goodman, 2000 ) . The design of the device means that maintenance fl ushing is only required monthly ( Eastridge and Lefor, 1995 ) . The other great advantage is that these devices are long lasting and can be punctured up to 2000 times before a device change is required. Ports have been reported as remaining in situ for up to fi ve years ( Burdon et al, 1998 ) .
Initial and long-term complications and disadvantages of TIPs have been documented in many studies. As with any surgical procedure pre-, intra-and post-operative complications are always a risk ( Ahmadi et al, 2006 ) . Biffi et al (1998) recorded incidence of catheter/port malfunction, catheter rupture and embolisation, venous thrombosis and infection. A further recorded complication is extravasation ( Ahmadi et al, 2006 ) .
Consider use for the same indications as a TCVC.
Conclusion
Both the techniques and indications for venous access are changing rapidly. It is imperative that healthcare professionals are kept up to date with the range of devices now available. This article has provided an overview of these devices and indications for their use in the clinical setting. In addition this article has provided the reader with knowledge of the advantages and disadvantages of each device to ensure the most appropriate device is used for each individual patient's circumstances. However, it is important to remember that the advantages and disadvantages of each device from the patient's perspective should also be taken into account in device selection.
